SHORT MINI-FUTURE - BRISTOL-MYERS SQUIBB | Market Closed - Börse Stuttgart 01:07:03 27/06/2024 am IST | ||
| 4.87 EUR | -0.41% |
|
| Current month | -1.42% | ||
| 1 month | -0.81% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 4.87 | -0.41% |
| 25/24/25 | 4.89 | +0.41% |
| 24/24/24 | 4.87 | -1.22% |
| 21/24/21 | 4.93 | -1.20% |
| 20/24/20 | 4.99 | +0.40% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 01:07 am IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VV39WG |
| ISIN | DE000VV39WG6 |
| Date issued | 28/06/2022 |
| Strike | 94.54 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.69 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.06 € |
|---|---|
| Lowest since issue | 1.39 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.19
USD
Average target price
53.19
USD
Spread / Average Target
+26.08%
- Stock Market
- Certificates
- Certificat
